MULTICLINIC EVALUATION OF TIMOLOL IN THE TREATMENT OF MILD-TO-MODERATE ESSENTIAL-HYPERTENSION

被引：21

作者：

ROFMAN, BA

KULAGA, SF

GABRIEL, MA

THIYAGARAJAN, B

NANCARROW, JF

ABRAMS, WB

机构：

来源：

HYPERTENSION | 1980年 / 2卷 / 05期

关键词：

D O I：

10.1161/01.HYP.2.5.643

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：643 / 648

页数：6

共 11 条

[1]

ALCOCER L, 1975, J INT MED RES, V3, P1

[2] USE OF BETA-ADRENORECEPTOR BLOCKING-DRUGS IN HYPERTENSION [J].

DOYLE, AE .

DRUGS, 1974, 8 (06) :422-431

[3] ANTIHYPERTENSIVE AND HEMODYNAMIC PROPERTIES OF NEW BETA-ADRENERGIC BLOCKING-AGENT TIMOLOL [J].

FRANCIOS.JA ;

FREIS, ED ;

CONWAY, J .

CIRCULATION, 1973, 48 (01) :118-124

[4] CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .4. ADVERSE-EFFECTS - CHOOSING A BETA-ADRENORECEPTOR BLOCKER [J].

FRISHMAN, W ;

SILVERMAN, R ;

STROM, J ;

ELKAYAM, U ;

SONNENBLICK, E .

AMERICAN HEART JOURNAL, 1979, 98 (02) :256-262

[5]

HENNING M, 1979, ACTA MED SCAND, P33

[6] COMPARISON OF TIMOLOL AND PROPRANOLOL IN ESSENTIAL HYPERTENSION [J].

LOHMOLLER, G ;

FROHLICH, ED .

AMERICAN HEART JOURNAL, 1975, 89 (04) :437-442

[7]

LUNDJOHANSEN P, 1976, ACTA MED SCAND, V199, P263

[8] PROPRANOLOL WITHDRAWAL REBOUND PHENOMENON - ACUTE AND CATASTROPHIC EXACERBATION OF SYMPTOMS AND DEATH FOLLOWING ABRUPT CESSATION OF LARGE DOSES OF PROPRANOLOL IN CORONARY-ARTERY DISEASE [J].

OLSON, HG ;

MILLER, RR ;

AMSTERDAM, EA ;

WOOD, M ;

BROCCHINI, R ;

MASON, DT .

AMERICAN JOURNAL OF CARDIOLOGY, 1975, 35 (01) :162-162

[9]

SCRIABINE A, 1973, ARCH INT PHARMACOD T, V205, P76

[10]

SIMON G, 1978, CLIN PHARMACOL THER, V23, P152

← 1 2 →